Drug Patents owned by Upsher Smith Labs
1. List of Qudexy Xr drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10363224 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(9 years from now) | |
| US8652527 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(9 years from now) | |
| US8889190 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(9 years from now) | |
| US9555005 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(9 years from now) | |
| US9101545 | UPSHER SMITH LABS | Extended-release topiramate capsules |
Mar, 2033
(9 years from now) | |
Drugs and Companies using TOPIRAMATE ingredient
Market Authorisation Date: 11 March, 2014
Treatment: Treatment of seizures
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
2. List of Tosymra drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8440631 | UPSHER SMITH LABS | Compositions for drug administration |
May, 2026
(2 years from now) | |
| US8268791 | UPSHER SMITH LABS | Alkylglycoside compositions for drug administration |
May, 2026
(2 years from now) | |
| US9283280 | UPSHER SMITH LABS | Compositions for drug administration |
May, 2026
(2 years from now) | |
| US11337962 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US10603305 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9974770 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9610280 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9211282 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jul, 2031
(8 years from now) | |
Drugs and Companies using SUMATRIPTAN ingredient
Market Authorisation Date: 25 January, 2019
Treatment: Acute treatment of migraine
Dosage: SPRAY;NASAL
3. List of Vogelxo drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9295675 | UPSHER SMITH LABS | Testosterone gel compositions and related methods |
Feb, 2034
(10 years from now) | |
| US8785426 | UPSHER SMITH LABS | Testosterone gel compositions and related methods |
Feb, 2034
(10 years from now) | |
| US9662340 | UPSHER SMITH LABS | Testosterone gel compositions and related methods |
Feb, 2034
(10 years from now) | |
Drugs and Companies using TESTOSTERONE ingredient
Market Authorisation Date: 04 June, 2014
Treatment: Method for transdermal delivery of testosterone
Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL
4. List of Zembrace Symtouch drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11364224 | UPSHER SMITH LABS | Pharmaceutical composition for treating migraine |
Jan, 2036
(12 years from now) | |
| US10537554 | UPSHER SMITH LABS | Pharmaceutical composition for treating migraine |
Jan, 2036
(12 years from now) | |
Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient
Market Authorisation Date: 28 January, 2016
Treatment: Treatment of migraine
Dosage: SOLUTION;SUBCUTANEOUS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic